1ZE7

Zinc-binding domain of Alzheimer's disease amyloid beta-peptide in water solution at pH 6.5

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	DQF-COSY	2.8mM in 50mM sodium phosphate buffer	90% H2O/10% D2O	0.1	6.5	ambient	278
2	2D TOCSY	2.8mM in 50mM sodium phosphate buffer	90% H2O/10% D2O	0.1	6.5	ambient	278
3	2D NOESY	2.8mM in 50mM sodium phosphate buffer	90% H2O/10% D2O	0.1	6.5	ambient	278
4	HSQC	2.8mM in 50mM sodium phosphate buffer	90% H2O/10% D2O	0.1	6.5	ambient	278
5	HMBC	2.8mM in 50mM sodium phosphate buffer	90% H2O/10% D2O	0.1	6.5	ambient	278

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	DMX	600

NMR Refinement
Method	Details	Software
simulated annealing	the structures are based on a total of 206 restraints, 201 are NOE-derived distance constraints, 5 dihedral angle restraints	XWINNMR

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	1000
Conformers Submitted Total Number	20
Representative Model	1 (closest to the average)

Additional NMR Experimental Information
Details	This structure was determined using standard 2D homonuclear techniques

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	XWINNMR	3.1	Bruker Biospin
2	data analysis	AURELIA	1.6	Bruker Biospin
3	structure solution	ICMD	2.7	Alexey K.Mazur
4	refinement	ICMD	2.7	Alexey K.Mazur

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.